Trinity Biotech
TRIB
#10174
Rank
NZ$31.58 M
Marketcap
NZ$1.65
Share price
1.32%
Change (1 day)
5.51%
Change (1 year)

P/E ratio for Trinity Biotech (TRIB)

P/E ratio as of December 2025 (TTM): -0.3325

According to Trinity Biotech 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.332473. At the end of 2023 the company had a P/E ratio of -0.6841.

P/E ratio history for Trinity Biotech from 2001 to 2024

PE ratio at the end of each year

Year P/E ratio Change
2023-0.6841-11.28%
2022-0.7710-102.29%
202133.7-369.46%
2020-12.51586.44%
2019-0.7422-65.74%
2018-2.17-18.82%
2017-2.6770.5%
2016-1.57-112.46%
201512.6-45.08%
201422.9-58.9%
201355.7230.87%
201216.8

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
OraSure Technologies
OSUR
-3.04 813.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
-12.3 3,611.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
15.8-4,837.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Chembio Diagnostics
CEMI
-0.3792 14.04%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-1.69 407.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
32.4-9,845.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
45.7-13,857.45%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.